APA

Hoflack J., Mueller L., Fowler S., Braendli-Baiocco A., Flint N., Kuhlmann O., Singer T. & Roth A. (20120426). Monitoring Cyp2b10 mRNA expression at cessation of 2-year carcinogenesis bioassay in mouse liver provides evidence for a carcinogenic mechanism devoid of human relevance: the dalcetrapib experience. : Toxicology and applied pharmacology.

Chicago

Hoflack J-C, Mueller L, Fowler S, Braendli-Baiocco A, Flint N, Kuhlmann O, Singer T and Roth A. 20120426. Monitoring Cyp2b10 mRNA expression at cessation of 2-year carcinogenesis bioassay in mouse liver provides evidence for a carcinogenic mechanism devoid of human relevance: the dalcetrapib experience. : Toxicology and applied pharmacology.

Harvard

Hoflack J., Mueller L., Fowler S., Braendli-Baiocco A., Flint N., Kuhlmann O., Singer T. and Roth A. (20120426). Monitoring Cyp2b10 mRNA expression at cessation of 2-year carcinogenesis bioassay in mouse liver provides evidence for a carcinogenic mechanism devoid of human relevance: the dalcetrapib experience. : Toxicology and applied pharmacology.

MLA

Hoflack J-C, Mueller L, Fowler S, Braendli-Baiocco A, Flint N, Kuhlmann O, Singer T and Roth A. Monitoring Cyp2b10 mRNA expression at cessation of 2-year carcinogenesis bioassay in mouse liver provides evidence for a carcinogenic mechanism devoid of human relevance: the dalcetrapib experience. : Toxicology and applied pharmacology. 20120426.